Lutein and zeaxanthin: what they do for eyes, from premature babies to aging adults
Lutein is sold as an everyday eye supplement, and the EU authorized none of the 17 claims made for it. Its clearest result is in premature babies, where a Cochrane review pooling 4 trials in 532 infants found it probably halves severe retinopathy of prematurity, while in adults with macular degeneration the effect is small and rests on low-certainty evidence.
Every statement on this page is tied to a source. The badge shows what kind of evidence stands behind it. Evidence A is a meta-analysis or systematic review. E is the position of an expert body without its own analysis. Click "source" for the exact sentence we took it from. How we verify →
A · 4B · 4C · 2E · 3
13 statements. A meta-analysis · B randomized trial · C observational · D laboratory · E position of an expert body. A page leaning on E is reporting consensus rather than weighing trials, and you can see that before you read a word of it.
How much you need
- Mature raw spinach averages about 7.5 mg of lutein per 3.5 oz (100 g) and raw kale about 6.3 mg of lutein plus zeaxanthin, while one large egg yolk sample averages 0.6 mg per 3.5 oz (100 g) with a wide spread. — USDA Foundation Foods samples Evidence E source
- In an uncontrolled 4-week study in 19 Japanese men with high cholesterol, adding one soft-boiled egg a day raised serum lutein plus zeaxanthin above baseline without raising LDL. — 19 moderately hypercholesterolemic Japanese men, 4 weeks Evidence C source
How well your body absorbs it
- In a crossover trial in 16 young men, adding 3 scrambled eggs to a raw vegetable salad raised lutein and zeaxanthin absorption 4- to 5-fold. — 16 healthy young men, single test meals, 10 h sampling Evidence B source
- In a crossover trial in 16 people, salad eaten with olive oil gave 55% higher carotenoid absorption than with coconut oil, and emulsified fat 40% more than non-emulsified. — 16 subjects, salad with 28 g of test fat, 10 h sampling Evidence B source
- In a crossover trial in 24 adults, 6 mg a day of marigold lutein raised serum lutein 2.4-fold within 15 days, with no difference between free and ester forms. — 24 healthy adults aged 20-35 and 50-65, two months per form Evidence B source
Who is most likely to fall short
- A Cochrane review of 5 RCTs in preterm infants found lutein plus zeaxanthin probably halves severe retinopathy of prematurity (stage 3+, 4 studies, 532 infants), with no adverse effects reported. — preterm infants under 37 weeks, 5 RCTs (666 infants) in the review, 4 RCTs (532 infants) for ROP stage 3+ Evidence A source
What the evidence does and does not show
- A Cochrane review found lutein/zeaxanthin alone gave similar or slightly lower risk of progression to late macular degeneration than control (RR 0.94), on low-certainty evidence from 4,176 people. — people with AMD, mostly AREDS2, 4,176 participants Evidence A source
- In 10-year AREDS2 follow-up of 3,882 people, lutein/zeaxanthin lowered progression to late AMD by 15% versus beta-carotene and did not significantly raise lung cancer odds, unlike beta-carotene. — 3,882 participants with intermediate AMD, mean age 72, 10 years Evidence B source
- In 8 RCTs of 1,176 people with macular degeneration, lutein and zeaxanthin improved visual acuity by 0.04 logMAR, with about 0.003 logMAR more per extra mg a day. — 1,176 AMD patients, 8 RCTs Evidence A source
- A systematic review of 6 RCTs in 584 people with dry eye found 3 to 20 mg a day of lutein gave mixed results, too varied to pool. — 584 subjects with dry eye disease, 6 RCTs, 4 to 12 weeks Evidence A source
- An umbrella review of 24 meta-analyses links higher dietary lutein to lower risk of macular degeneration, cataract, heart disease and stroke, on observational data. — 24 meta-analyses covering 29 outcomes Evidence C source
- The EU did not authorize claims that lutein promotes healthy eye function, protects the retina from oxidation or filters blue light, and none of 17 lutein claims in the snapshot were authorized. — EU claims register, claim POL-HC-7520 Evidence E source
What too much does
- A 2012 Veterans Affairs review notes lutein has been linked to harmless yellowing of the skin in two trials at 15 mg a day for 4 to 5 months. — adults in supplement trials Evidence E source
What to do with this
Leafy greens are the richest food source. USDA samples of raw mature spinach average about 7.5 mg of lutein per 3.5 oz (100 g), and raw kale about 6.3 mg of lutein plus zeaxanthin, from only three samples. Egg yolk is far lower at about 0.6 mg per 3.5 oz (100 g), with a wide spread between samples.
Eat the greens with some fat. In 16 young men, adding three scrambled eggs to a raw vegetable salad raised lutein and zeaxanthin absorption 4- to 5-fold over a single meal, though eggs carry some lutein of their own. In another 16 people, salad with olive oil gave 55 percent higher total carotenoid absorption than with coconut oil.
If you have intermediate macular degeneration, the AREDS2 formula is a conversation for your eye doctor. Over 10 years in 3,882 people, the version with lutein and zeaxanthin cut progression to late disease by 15 percent compared with the version containing beta-carotene, and it did not significantly raise lung cancer odds the way beta-carotene did.
For dry eye, the trials were too mixed to give a clear reason to buy a capsule, and the EU did not authorize the claim that lutein promotes healthy eye function. For a premature baby, whether lutein is given is a decision for the neonatal team.
Where to get it from food
USDA does not report lutein and zeaxanthin for individual foods, so this site cannot rank foods by it. The sections above name the foods the studies themselves looked at.
The bottom line
The strongest lutein evidence comes from neonatal wards. Severe retinopathy of prematurity fell by about half (relative risk 0.49), at moderate certainty, in 4 trials with 532 infants from Italy and the United States only. Retinopathy of any stage and deaths did not differ significantly. In adults with macular degeneration a Cochrane review resting almost entirely on AREDS2 found lutein and zeaxanthin may give similar or slightly lower risk of late disease than control (relative risk 0.94, 95% CI 0.87 to 1.01). Nearly everyone in that trial also took the AREDS vitamin formula. Across 8 trials in 1,176 patients, visual acuity improved by 0.04 logMAR, roughly two letters on an eye chart. For dry eye, 6 trials using 3 to 20 mg a day gave results too mixed to pool. Observational data link higher dietary lutein to lower rates of macular degeneration, cataract, heart disease and stroke, and an association is all they can show. The documented side effect is cosmetic, a harmless yellowing of the skin in two trials at 15 mg a day for 4 to 5 months, with no frequency given. The preterm trials reported no adverse effects. We have no card on lutein supplements in pregnancy or alongside medicines, and that is a gap in what we hold.
Daily Values are one number for everyone. Yours depend on your body, activity and goal. Bioma works out your personal targets and shows every meal against them, from a photo. About Bioma →
Foods discussed in this guide
- Egg yolk: dense in cholesterol, and two eggs a day did not significantly raise LDL in one small trial
- Kale: 325 percent on the label, 4.7 percent in the blood
- Spinach: the oxalate story is mostly wrong
- Coconut: almost every trial poured the oil
- Coconut oil: a saturated fat that raises LDL cholesterol
- Olive oil: what the cohorts see and the trials do not
- Olives: a salt food with thin health evidence
- Leafy greens: strong in the cohorts, flat in the biggest trial
- Raw vegetables: what eating them uncooked changes, and what it does not
- Vegetables: small effects, measured honestly
Sources
- lutr3-11 · Position of an expert body · dataset
Spinach, mature: Lutein 7451.0 ug per 100 g, range 5020.0-9630.0, 8 samples; Kale, raw: Lutein + zeaxanthin 6260.0 ug, range 4460.0-8560.0, 3 samples; Eggs, Grade A, Large, egg yolk: Lutein 612.0 ug, range 359.0-1400.0, 24 samples
(value from the source's table, not a sentence)
USDA FoodData Central, Foundation Foods, release 2026-04-30 (Spinach, mature; Kale, raw; Eggs, Grade A, Large, egg yolk) · checked 2026-10-02 · independently re-checked - lutr3-09 · Observational data · clinical trial
Nineteen male Japanese adults (total cholesterol [TC]>5.2mmol/L) participated, consuming one soft boiled egg per day for 4weeks in addition to their habitual diet. ... At weeks 2 and 4, the subjects' serum lutein+zeaxanthin concentrations were significantly higher than their baseline values
Food Res Int, 2017 · checked 2026-10-02 · independently re-checked - lutr3-07 · Randomized controlled trial(s) · RCT
Healthy young men (n = 16) consumed the same salad (all served with 3 g canola oil) with no egg (control), 75 g scrambled whole eggs (1.5 eggs) [low egg (LE)], and 150 g scrambled whole eggs (3 eggs) [high egg (HE)] (a randomized crossover design). ... The TRL AUC(0-10h) of lutein and zeaxanthin increased 4-5-fold (P < 0.001)
Am J Clin Nutr, 2015 · checked 2026-10-02 · independently re-checked - lutr3-08 · Randomized controlled trial(s) · RCT
Similarly, the positive iAUC1-10h of TC, α-carotene, and lycopene were 55.2%, 110.8%, and 45.8%, respectively, higher with olive oil than with coconut oil. Emulsified fat induced 40.0% greater positive iAUC1-10h of TC than nonemulsified fat.
Am J Clin Nutr, 2023 · checked 2026-10-02 · independently re-checked - lutr3-06 · Randomized controlled trial(s) · RCT
Serum lutein increased 2.4-fold on day 15 (up to 0.81 and 0.90 µmol/L with free and ester lutein, respectively) and was maintained until the end of the study. Serum Zeax increased 1.7-fold. There were no differences in serum Lut responses to free or ester lutein at any time point.
Nutrients, 2024 · checked 2026-10-02 · independently re-checked - lutr3-01 · Meta-analysis or systematic review · Cochrane review
Lutein and zeaxanthin supplementation probably reduces the incidence of ROP stage 3 and above (RR 0.49, 95% CI 0.29 to 0.81; P = 0.005; I2 = 0%; 4 studies, 532 infants; moderate-certainty evidence). ... No adverse effects were reported in either group.
Cochrane Database Syst Rev, 2025 · checked 2026-10-02 · independently re-checked - lutr3-02 · Meta-analysis or systematic review · Cochrane review
People taking lutein/zeaxanthin may have similar or slightly reduced risk of progression to late AMD (RR 0.94, 95% CI 0.87 to 1.01), neovascular AMD (RR 0.92, 95% CI 0.84 to 1.02), and geographic atrophy (RR 0.92, 95% CI 0.80 to 1.05) compared with control (1 study, 4176 participants, 6891 eyes; low-certainty evidence).
Cochrane Database Syst Rev, 2023 · checked 2026-10-02 · independently re-checked - lutr3-03 · Randomized controlled trial(s) · RCT follow-up
At 10 years, the odds ratio (OR) of having lung cancer was 1.82 (95% CI, 1.06-3.12; P = .02) for those randomly assigned to beta carotene and 1.15 (95% CI, 0.79-1.66; P = .46) for lutein/zeaxanthin. ... A direct analysis of lutein/zeaxanthin vs beta carotene showed the HR for late AMD was 0.85 (95% CI, 0.73-0.98; P = .02).
JAMA Ophthalmol, 2022 · checked 2026-10-02 · independently re-checked - lutr3-04 · Meta-analysis or systematic review · meta-analysis of RCTs
Eight RCTs involving 1176 AMD patients were included in the meta-analysis. Xanthophyll carotenoids supplementation was associated with significant decrease in logMAR levels compared with the placebo group (WMD, -0.04; 95% CI, -0.06 to -0.03), and during intervention, each 1-mg/day increase in these carotenoids supplementation was related to a 0.003 reduction in logMAR level of VA.
Invest Ophthalmol Vis Sci, 2014 · checked 2026-10-02 · independently re-checked - lutr3-05 · Meta-analysis or systematic review · systematic review of RCTs
Six randomized controlled trials (RCTs) involving 584 subjects were included. Meta-analysis was not conducted due to heterogeneity in study designs, dosages, and outcome measures. RESULTS: Lutein dosages ranged from 3 mg/day to 20 mg/day, with treatment durations from 4 to 12 weeks.
Int J Vitam Nutr Res, 2024 · checked 2026-10-02 · independently re-checked - lutr3-10 · Observational data · umbrella review
Dietary lutein intake was inversely associated with age-related macular degeneration, age-related cataracts, coronary heart disease, stroke, oesophageal cancer, non-Hodgkin lymphoma, metabolic syndrome, and amyotrophic lateral sclerosis.
Food Chem, 2021 · checked 2026-10-02 · independently re-checked - lutr3-14 · Position of an expert body · regulatory decision
POL-HC-7520 Lutein Lutein promotes healthy eye function. Lutein and zeaxanthin help protect the retina against oxidation / from oxidative stress. Lutein is a constituent of the macular pigment. Lutein and zeaxanthin are deposited naturally in the macula and lens. Lutein and zeaxanthin are highly and selectively accumulated in the macula and lens / in the retina Lutein contributes to eye health. Lutein helps maintain the normal function of the macula. Lutein contributes to a healthy macula and retina. Lutein – nutrition for the eyes. Lutein contributes to the protection of vision. Lutein is important for macular pigment density. Lutein and zeaxanthin help protect the retina against oxidation / from oxidative stress. Lutein und zeaxanthin are natural antioxidants for the eye. Lutein helps fight free radicals in the eye. Lutein and zeaxanthin are natural filters of visible blue light. Lutein and zeaxanthin help protect the eye against harmful effects of light exposure. Lutein help protect the eye against visible light damage Non-authorised
(value from the source's table, not a sentence)
EU Register on nutrition and health claims, claim POL-HC-7520, snapshot 2026-09-21 · checked 2026-10-02 · independently re-checked - lutr3-12 · Position of an expert body · agency report
Lutein has also been associated with carotenodermia. A narrative review of carotenoids44 cited two trials of lutein in which this effect occurred, at daily doses of 15 mg for 4 to 5 months.45, 46
Department of Veterans Affairs (US), Nutritional Supplements for Age-Related Macular Degeneration: A Systematic Review, 2012 · checked 2026-10-02 · independently re-checked
Review. Last updated 2026-10-08. Reviewed for evidence level, dose and population context, completeness of cautions, and claims a reader could misread. Bioma Learn has no human medical reviewer at this time, and we say so rather than invent one. Methodology. This is information, not medical advice.